![Jim Dowell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jim Dowell
Profile
Jim Dowell worked as a Vice President-Biopharmaceutics at Ceptaris Therapeutics, Inc.
Former positions of Jim Dowell
Companies | Position | End |
---|---|---|
Ceptaris Therapeutics, Inc.
![]() Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Corporate Officer/Principal | - |
Experiences
Positions held
Linked companies
Private companies | 1 |
---|---|
Ceptaris Therapeutics, Inc.
![]() Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Health Technology |
- Stock Market
- Insiders
- Jim Dowell